Stocks
Affimed (AFMD) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 2 117% | 2 117% | 14 197% | 14 197% | 2 546% | 11 541% | |||
| Changes by years, y/y, % | -9 245pp | 0pp | +12 081pp | 0pp | -11 651pp | -12.2% | |||
Affimed. R&D/CAPEX, %
Affimed. R&D/CAPEX, changes, pp
Affimed (AFMD) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2024Q1 | 2023Q4 | 2024Q2 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 669.9% | 1 539 100% | 3 665% | 61 721% | 1 539 100% | 11 541% | ||
| Changes by years, y/y, % | -25 720pp | -4 643pp | -780 712pp | |||||
| Changes by quarters, q/q, % | -841 763pp | +1 538 430pp | -1 535 435pp | +58 056pp | +1 477 379pp | |||
